Review Article
Infectious Diseases
Key Takeaways
- Hospitalised patients in Malaysia showed the highest prevalence of microsporidiosis at approximately 28.3%, significantly higher than other studied risk groups.
- HIV/AIDS patients and other immunocompromised individuals are at substantially elevated risk, though microsporidiosis can also affect immunocompetent people.
- Waterborne transmission is a major concern in tropical climates like Malaysia, where environmental contamination of water sources can facilitate spread.
- Diagnosis remains challenging because microsporidial spores are extremely small and easily missed by conventional laboratory methods.
What Is Microsporidiosis?
Microsporidiosis is an infection caused by microsporidia — a group of obligate intracellular parasitic organisms that were historically classified as protozoa but are now recognised as highly specialised fungi. These organisms produce remarkably small spores, typically ranging from 1 to 4 micrometres in size, which makes them among the smallest eukaryotic pathogens capable of infecting humans.
More than 1,400 species of microsporidia have been described across the animal kingdom, but only about 17 species are known to cause disease in humans. The most commonly reported species in human infections are Enterocytozoon bieneusi and Encephalitozoon intestinalis, both of which primarily cause gastrointestinal illness characterised by chronic diarrhoea, malabsorption, and wasting.
The infection gained significant medical attention during the HIV/AIDS epidemic of the 1980s and 1990s, when it was identified as one of the opportunistic infections causing severe chronic diarrhoea in patients with advanced immunosuppression. However, increasing evidence has demonstrated that microsporidiosis is not limited to immunocompromised populations — cases have been documented in immunocompetent travellers, children, and elderly individuals, particularly in tropical and subtropical regions.
Why Malaysia Is Particularly Relevant
Malaysia’s tropical climate, characterised by high temperatures and humidity throughout the year, creates environmental conditions highly favourable for the survival and transmission of microsporidial spores in water and soil. Several features of the Malaysian context make microsporidiosis a relevant public health concern.
The country’s water systems, while generally well-managed in urban areas, may present contamination risks in rural and semi-urban regions where water treatment infrastructure is less developed. Microsporidial spores are resistant to many conventional water treatment methods and can persist in environmental water sources for extended periods. Studies of recreational water, agricultural water, and drinking water sources in tropical countries have repeatedly detected microsporidial contamination.
Malaysia also has a notable HIV-positive population. According to the Malaysian Ministry of Health, the country had recorded over 120,000 cumulative HIV cases by the late 2010s. Given that severe immunosuppression is the single strongest risk factor for symptomatic microsporidiosis, this population requires particular vigilance for opportunistic infections including microsporidia.
Prevalence Across Risk Groups in Malaysia
Research published in the Malaysian Journal of Public Health Medicine reviewed the available evidence on microsporidiosis prevalence across different population groups in the country. The findings revealed considerable variation in infection rates depending on the population studied.
| Risk Group | Estimated Prevalence | Key Observations |
|---|---|---|
| Hospitalised patients | ~28.3% | Highest prevalence among all groups studied; many had gastrointestinal symptoms |
| HIV/AIDS patients | Variable (12–30%) | Risk increases sharply when CD4 count drops below 100 cells/µL |
| Immunocompromised (non-HIV) | Moderate | Includes organ transplant recipients, cancer patients on chemotherapy |
| Orang Asli communities | Elevated | Limited access to treated water; higher environmental exposure |
| General population | Lower but documented | Cases reported even in immunocompetent individuals |
The finding that hospitalised patients showed the highest prevalence at approximately 28.3% is notable because it suggests that microsporidiosis may be significantly underdiagnosed in clinical settings. Many patients presenting with chronic diarrhoea or unexplained gastrointestinal symptoms may harbour microsporidial infections that go undetected because routine stool examinations are not optimised for identifying these extremely small organisms.
HIV-Positive Patients
Among HIV-positive individuals, microsporidiosis prevalence has been found to correlate strongly with the degree of immunosuppression. Patients with CD4 lymphocyte counts below 100 cells per microlitre are at the greatest risk, experiencing chronic watery diarrhoea that can lead to severe dehydration, malnutrition, and significant weight loss. The introduction of highly active antiretroviral therapy (HAART) has substantially reduced the burden of microsporidiosis in HIV-positive populations worldwide by restoring immune function, but the infection remains a concern for patients who are newly diagnosed, not yet on treatment, or experiencing treatment failure.
Indigenous Communities
Studies of Orang Asli (indigenous) communities in Peninsular Malaysia have consistently reported elevated rates of various intestinal parasitic infections, and microsporidiosis appears to follow this pattern. These communities often rely on untreated river water for drinking and daily use, live in close proximity to animals (a potential zoonotic reservoir), and may have limited access to healthcare facilities where the infection could be diagnosed. The intersection of environmental exposure, limited healthcare access, and potential nutritional deficiencies makes these communities particularly vulnerable.
How Microsporidiosis Spreads
The primary route of transmission is through ingestion of microsporidial spores, most commonly via contaminated water or food. The spores are shed in the faeces and urine of infected humans and animals, contaminating environmental water sources. Other documented or suspected transmission routes include direct person-to-person contact (faecal-oral), inhalation of spores (for species that cause respiratory or disseminated disease), and possible sexual transmission.
Importantly, microsporidia have a wide animal host range. Domestic animals, livestock, and wildlife can all harbour species capable of infecting humans, raising the possibility of zoonotic transmission. In Malaysia, where close human-animal contact occurs in agricultural settings and rural communities, this zoonotic potential warrants attention.
Clinical Presentation and Symptoms
The clinical manifestations of microsporidiosis depend on the species involved and the immune status of the patient. The most common presentation is chronic diarrhoea, but microsporidia can affect virtually any organ system.
In immunocompromised patients, the most frequent symptoms include persistent watery diarrhoea lasting weeks to months, abdominal cramping and bloating, progressive weight loss and wasting, malabsorption of nutrients leading to nutritional deficiencies, and fatigue and generalised weakness. Disseminated infections can involve the kidneys, sinuses, lungs, eyes, and central nervous system.
In immunocompetent individuals, microsporidiosis tends to be self-limiting, presenting as acute diarrhoea lasting one to two weeks. However, some studies have suggested that even in immunocompetent people, the infection may persist at subclinical levels and contribute to chronic gastrointestinal complaints.
Diagnosis: A Persistent Challenge
One of the most significant barriers to understanding the true burden of microsporidiosis is the difficulty of diagnosis. Microsporidial spores are extremely small — Enterocytozoon bieneusi spores measure only about 1.5 by 0.5 micrometres, making them among the smallest organisms visible under light microscopy. Standard ova and parasite examinations used in most clinical laboratories are not designed to detect organisms of this size.
Specialised staining techniques, particularly modified trichrome staining (Weber’s chromotrope-based stain) and fluorescence staining with calcofluor white or Uvitex 2B, can identify microsporidial spores in stool and tissue samples. However, these techniques require experienced microscopists and are not routinely available in many Malaysian hospitals and clinics.
Molecular methods, particularly polymerase chain reaction (PCR), offer the highest sensitivity and specificity for microsporidial detection and can identify the infecting species. PCR-based diagnosis is increasingly available in reference laboratories but has not yet been integrated into routine clinical practice in most Malaysian healthcare settings.
Treatment Options
Treatment of microsporidiosis depends on the species involved and the patient’s immune status. For infections caused by Encephalitozoon species, albendazole (400 mg twice daily for two to four weeks) is the treatment of choice and has shown good efficacy. For Enterocytozoon bieneusi, which is the most common species but does not respond well to albendazole, fumagillin has been used with success in some studies but is not widely available and carries potential side effects including thrombocytopaenia.
For HIV-positive patients, the most important therapeutic intervention is initiation or optimisation of antiretroviral therapy. Immune reconstitution through effective HAART frequently leads to clearance of microsporidial infection without the need for specific antimicrobial treatment.
Implications for Malaysian Healthcare
This review highlights several areas where Malaysian public health practice could be strengthened. First, clinical laboratories should consider incorporating specialised staining techniques for microsporidia in the investigation of patients with chronic diarrhoea, particularly those who are immunocompromised. Second, waterborne transmission underscores the importance of ensuring safe water supplies, especially in rural and indigenous communities. Third, awareness among clinicians needs to be raised — microsporidiosis should be included in the differential diagnosis of chronic diarrhoea, not only in HIV-positive patients but also in hospitalised and elderly individuals. Finally, further epidemiological studies are needed to establish the true burden of microsporidiosis across Malaysia’s diverse populations and geographical regions.
What You Can Do to Reduce Risk
While microsporidiosis is not a condition most healthy individuals need to worry about on a daily basis, certain practical steps can reduce the risk of exposure. These include drinking treated or boiled water, especially when travelling to rural areas or regions with uncertain water quality; practising thorough hand hygiene, particularly before eating and after contact with soil or animals; and ensuring that immunocompromised family members receive regular medical follow-up that includes screening for opportunistic infections when symptomatic.
For healthcare workers, maintaining awareness that microsporidiosis can present with non-specific symptoms and that routine stool examination may miss the infection is essential for timely diagnosis and treatment.
Limitations of Current Evidence
The available evidence on microsporidiosis in Malaysia, while informative, has several limitations. Most studies have focused on specific risk groups rather than the general population, making it difficult to estimate overall national prevalence. Diagnostic methods have varied across studies, which may affect comparability of prevalence estimates. Many studies have been cross-sectional, providing prevalence data at a single time point without information on trends over time. Additionally, the geographic coverage of studies has been limited, with most research conducted in Peninsular Malaysia and relatively little data from Sabah and Sarawak.